Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
256.00
Ask:
265.00
Spread: 9.00 (3.516%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Trading Statement

23 Jul 2025 07:00

RNS Number : 1038S
Wilmington PLC
23 July 2025
 

23 July 2025

Wilmington plc

 

Year-end trading update

 

Wilmington plc, (LSE: WIL, 'Wilmington', 'the Group') the provider of data, information, education and training in the global Governance, Risk and Compliance ('GRC') markets, today provides a trading update for the year ended 30 June 2025.

 

Revenue growth from the Group's ongoing* businesses is expected to be 11%, led by both recent acquisitions in the HSE sector delivering double-digit percentage growth.

 

As at the half year, seven out of nine businesses grew year on year. Following the portfolio changes last year of two disposals and two acquisitions, and the continuing disruption in the US healthcare insurance market impacting our US events business over a full year, reported revenue is expected to be £101.5m (2024: £126m), with organic** revenue also having decreased 1% due to the US.

 

Operating profit from ongoing* businesses is expected to be up 11%, adjusted*** profit before tax is expected to be £27.7m (2024: £27.6m), with adjusted PBT margin up to 27% (2024: 22%).

 

Cash conversion continued to be strong at 107% of profits, with Group net cash on 30 June 2025 at £41.9m (30 June 2024: £67.8m) after the completion of the acquisition of Phoenix Health & Safety on 25 October 2024 and spending £3.4m on share buybacks.

 

Wilmington expects to publish its year end results on 22 September 2025.

 

Mark Milner, Chief Executive Officer, commented:

 

"We have seen another year of good ongoing* revenue and profit growth with both measures increasing 11%, reflecting our focus on a slimmed down higher quality portfolio of growing businesses. Margins have also continued to improve and both of our recent acquisitions have seen double digit growth. This performance came against a tough macro backdrop, particularly in the US healthcare market which has seen continued disruption in the course of our H2.

 

"With the acquisition of Phoenix, we have continued to actively manage our portfolio of businesses and are pursuing various opportunities to invest our cash in acquisitions to improve the quality of revenue and profits."

 

*Ongoing - eliminating the effects of the impact of disposals, closures and businesses held for sale.

**Organic - Ongoing, eliminating acquisitions and exchange rate fluctuations

***Adjusted profit before tax (PBT) is calculated as PBT after adding back amortisation and impairment of intangible assets (except computer software) and profits/losses on disposals and business closures. Market consensus adjusted profit before tax is £27.0m.

 

For further information, please contact:

 

Wilmington plc

Mark Milner, Chief Executive Officer

Guy Millward, Chief Financial Officer

 

Meare Consulting

Adrian Duffield

 

 

020 7490 0049

 

 

 

 

07990 858548

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement this inside information is now considered to be in the public domain.

 

Notes to Editors

Wilmington plc is the recognised knowledge leader and partner of choice for data, information, education and training in the global Governance, Risk and Compliance (GRC) markets. Wilmington employs around 600 people and sells to around 120 countries. Wilmington is listed on the main market of the London Stock Exchange.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUUUORVWUBUAR
Date   Source Headline
25th May 20101:32 pmRNSDirector/PDMR Shareholding
24th May 20102:41 pmRNSDirector/PDMR Shareholding
17th May 20107:00 amRNSInterim Management Statement
5th May 20109:29 amRNSBlocklisting Interim Review
4th May 201010:41 amRNSTotal Voting Rights
6th Apr 201010:29 amRNSTotal Voting Rights
18th Mar 20104:34 pmRNSDirector/PDMR Shareholding
18th Mar 20103:16 pmRNSHolding(s) in Company
16th Mar 20102:26 pmRNSHolding(s) in Company
3rd Mar 20103:45 pmRNSTotal Voting Rights
25th Feb 20104:49 pmRNSHolding(s) in Company
25th Feb 20103:08 pmRNSHolding(s) in Company
25th Feb 20107:00 amRNSHalf Yearly Report
1st Feb 201010:44 amRNSTotal Voting Rights
12th Jan 20104:35 pmRNSPrice Monitoring Extension
4th Jan 20103:31 pmRNSTotal Voting Rights
3rd Dec 20095:06 pmRNSAnnual Information Update
1st Dec 20092:49 pmRNSTotal Voting Rights
12th Nov 200911:52 amRNSResult of AGM
11th Nov 20097:00 amRNSInterim Management Statement
4th Nov 200911:22 amRNSBlocklisting Review
3rd Nov 200911:40 amRNSTotal Voting Rights
15th Oct 200911:18 amRNSDirector/PDMR Shareholding
14th Oct 200912:31 pmRNSDirector/PDMR Shareholding
5th Oct 200911:25 amRNSTotal Voting Rights
23rd Sep 20094:14 pmRNSDirector/PDMR Shareholding
17th Sep 20097:00 amRNSFinal Results
2nd Sep 200911:17 amRNSTotal Voting Rights
2nd Sep 20099:30 amRNSNotice of Results
6th Aug 20094:41 pmRNSSecond Price Monitoring Extn
6th Aug 20094:35 pmRNSPrice Monitoring Extension
3rd Aug 200910:07 amRNSTotal Voting Rights
9th Jul 20097:00 amRNSTrading Update
1st Jul 200911:08 amRNSTotal Voting Rights
1st Jun 200911:29 amRNSTotal Voting Rights
14th May 20097:00 amRNSInterim Management Statement
1st May 200912:39 pmRNSTotal Voting Rights
24th Apr 20094:40 pmRNSSecond Price Monitoring Extn
24th Apr 20094:36 pmRNSPrice Monitoring Extension
20th Apr 20094:40 pmRNSSecond Price Monitoring Extn
20th Apr 20094:35 pmRNSPrice Monitoring Extension
8th Apr 200912:14 pmRNSDirector/PDMR Shareholding
1st Apr 200911:27 amRNSTotal Voting Rights
12th Mar 20093:44 pmRNSDirector/PDMR Shareholding
2nd Mar 20092:49 pmRNSVoting Rights and Capital
27th Feb 20092:27 pmRNSDirector/PDMR Shareholding
27th Feb 20092:25 pmRNSDirector/PDMR Shareholding
26th Feb 20097:00 amRNSInterim Results
3rd Feb 20095:26 pmRNSTotal Voting Rights
16th Jan 20094:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.